Mind Medicine (MindMed) Inc. (MNMD) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Find Mind Medicine (MindMed) Inc. (MNMD) short-term stock forecasts for 2025 by month and long-term price predictions for 2025 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest MNMD stock news and headlines.
1 Month Prediction
$19.29 [95.08%]
3 Month Prediction
$19.42 [96.36%]
6 Month Prediction
$17.75 [79.45%]
1 Year Prediction
$23.03 [132.91%]
3 Year Prediction
$38.75 [291.78%]
5 Year Prediction
$54.46 [450.66%]
About Mind Medicine (MindMed) Inc.
Mind Medicine (MindMed) Inc. is a biotechnology company based in New York. It develops treatments using psychedelic and psychoplastogenic drugs that treats brain health disorders.
MindMed was founded in May 2019 by Jamon Rahn and Stephen Hurst. Rahn had personal experiences with mental health and addiction, which drove his interest in psychedelics. The company acquired the 18-MC drug program that aims at treating opioid withdrawal, and in June 2019. MindMed became the first psychedelic pharmaceutical company to go public in March 2020.
MindMed's lead product candidate is MM-120, a form of lysergide D-tartrate (LSD). These are used to treat generalized anxiety disorder (GAD). Another key program is MM-402, the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), which is in Phase 1 clinical trials. These address core symptoms of autism spectrum disorder (ASD).
Mind Medicine (MindMed) Inc. (MNMD) Historical Performance
IPO Date
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) went public on 27 April, 2021.
Change
Since inception, MNMD has increased by 90.01%. In the last 5 years, MNMD has risen from $8.40 to $9.89, a minor 17.74% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $58.65 and a low of $2.20.
52 Week Range
$4.5
$12.22
The current price $9.89 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
MNMD Stock Price History
Based on MNMD stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the MNMD stock has risen from $0.75 - $45.75 to $6.79 - $9.89, which is up 975.44%. Currently, the stock follows upward trend.
Here, we have calculated stock range of MNMD, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $0.75 - $45.75 | $10.8 | 1292.65 | 1 Year Change |
| 2021 | $20.7 - $58.65 | $42.48 | 5377.76 | 2 Year Change |
| 2022 | $2.2 - $18.3 | $10.02 | 1192.07 | 3 Year Change |
| 2023 | $2.56 - $4.93 | $3.58 | 361.64 | 4 Year Change |
| 2024 | $3.86 - $9.52 | $7.25 | 834.88 | 5 Year Change |
| 2025 | $6.79 - $9.89 | $8.34 | 975.44 | 6 Year Change |
MNMD Price Performance
6-Month Performance
MNMD stock jumped by 73.81% in the last six months.
1-Year Performance
The stock has trended upwards by 5.21% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 40.60%.
5-Year Performance
In the last 5 years, the stock has gone up by 17.74%.
According to Mind Medicine (MindMed) Inc.'s historical data, below graph gives us the exact picture of how the MNMD stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
5,346.43% ↑
2021
54.75% ↓
2022
89.37% ↓
2023
66.36% ↑
2024
90.16% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Mind Medicine (MindMed) Inc. (MNMD) Financials & Stock Analysis
Market Capitalization
Mind Medicine (MindMed) Inc. has a market capitalization of $725.25M, which places MNMD in the small-cap category.
Fundamental Analysis
EPS: $-0.18 (Q3), $-2.44 (1Y)
EPS increased 125.00% since last quarter, and increased 32.61% since last year.
Net Income: $-13.68 M (Q3), $-95.73 M (1Y)
Net Income increased 133.75% since last quarter, and increased 68.55% since last year.
Free Cash Flow: $-17.19 M (Q3), $-64.36 M (1Y)
Free Cash Flow decreased N/A since last quarter, and increased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for MNMD stock. These indicators help you understand Mind Medicine (MindMed) Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for MNMD stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $7.83 |
| SMA50 | $7.43 |
| SMA200 | $7.30 |
| RSI | 72.69 |
| Beta | 2.40 |
SMA20 < Current Price
This signals MNMD stock is in short-term bullish momentum.
SMA50 < Current Price
This signals MNMD stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals MNMD stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for MNMD stock is Bullish. Out of all indicators, 5 indicates bullish signals, 4 signals bearish trends and 0 gives neutral trends. The MNMD stock forecast was last updated on 18 February, 2025.
Mind Medicine (MindMed) Inc. (MNMD) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $20.26 by the end of 2025, and can reach around $22.22 to $29.94 in 2026. And, the long-term forecast suggests that the stock may further jump to $40.89 - $39.80 in 2028, and $85.79 - $32.43 by 2031. So, the MNMD stock shows a strong upward trend in the next several years.
Short-term MNMD Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $19.29 | 95.05% |
| 2025-04 | $19.84 | 100.61% |
| 2025-05 | $19.42 | 96.36% |
| 2025-06 | $18.14 | 83.42% |
| 2025-07 | $20.59 | 108.19% |
| 2025-08 | $17.75 | 79.47% |
| 2025-09 | $19.09 | 93.02% |
| 2025-10 | $18.68 | 88.88% |
| 2025-11 | $19.62 | 98.38% |
| 2025-12 | $20.26 | 104.85% |
In 2025, the MNMD stock price is expected to fluctuate between $17.75 and $20.59. According to the monthly forecast, the stock could rise to $20.26 by December 2024. If compared to the MNMD's current price, the stock could gain 104.85% by the end of this year.
Long-term MNMD Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $22.22 | $21.52 | $29.94 | 202.73% |
| 2027 | $19.58 | $31.92 | $34.88 | 252.68% |
| 2028 | $40.89 | $36.83 | $39.80 | 302.43% |
| 2029 | $41.32 | $30.86 | $28.20 | 185.14% |
| 2030 | $48.21 | $18.04 | $38.14 | 285.64% |
| 2031 | $85.79 | $66.75 | $32.43 | 227.91% |
| 2032 | $75.72 | $84.08 | $98.05 | 891.41% |
| 2033 | $53.54 | $68.29 | $98.95 | 900.51% |
| 2034 | $121.44 | $60.71 | $98.16 | 892.52% |
| 2035 | $50.88 | $117.58 | $96.73 | 878.06% |
| 2036 | $98.34 | $153.32 | $80.07 | 709.61% |
| 2037 | $115.06 | $131.46 | $125.39 | 1167.85% |
| 2038 | $153.78 | $118.41 | $97.08 | 881.6% |
| 2039 | $126.79 | $104.07 | $97.10 | 881.8% |
| 2040 | $141.97 | $64.06 | $157.58 | 1493.33% |
| 2041 | $154.53 | $113.65 | $181.46 | 1734.78% |
| 2042 | $144.17 | $144.76 | $170.00 | 1618.91% |
| 2043 | $131.25 | $167.19 | $143.90 | 1355.01% |
| 2044 | $93.75 | $131.92 | $222.73 | 2152.07% |
| 2045 | $112.77 | $233.30 | $205.17 | 1974.52% |
| 2046 | $194.70 | $201.66 | $205.81 | 1980.99% |
| 2047 | $194.19 | $195.21 | $204.26 | 1965.32% |
| 2048 | $84.20 | $151.95 | $220.13 | 2125.78% |
| 2049 | $255.81 | $191.65 | $288.50 | 2817.09% |
| 2050 | $253.64 | $168.42 | $186.19 | 1782.61% |
| 2051 | $250.70 | $204.07 | $192.46 | 1846.01% |
Mind Medicine (MindMed) Inc. (MNMD) Stock Price Prediction & Forecast 2025
At the start of 2025, the MNMD stock was at $6.79. Today, it is trading at $9.89, which is 45.66% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $20.26 by December 2025 with a 104.85% change.
Mind Medicine (MindMed) Inc. (MNMD) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the MNMD stock. During this period, the MNMD's price is forecasted to shift from $22.22 to $38.14, which is 71.65% gain.
In 2026, the stock would possibly open at $22.22, descends to $21.52 by mid-year, and wraps up at $29.94, reflecting a 202.72% increase from today's price. Further moving to 2030, the stock can kick off the year at $48.21, drop to $18.04 by mid-year, and finish at $38.14, which is 285.63% change from current price.
Mind Medicine (MindMed) Inc. (MNMD) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $85.79 to $157.58, which is up 227.86%
In 2031, we can expect MNMD to fluctuate between $32.43 and $85.79, a shift indicating a 227.86% gain by year-end compared to current price. And Until 2040, MNMD can likely vary from $141.97 to $157.58. By the end of 2040, the stock could record a 1493.31% rise from today's stock price.
Mind Medicine (MindMed) Inc. (MNMD) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the MNMD stock can see an an upturn from $154.53 to $186.19 in this period. In 2041, the stock can experience a low of $113.65 by mid-year, closing the year at $181.46. This results in a 1049.10% increase from today.
Moving towards the end of 2050, MNMD is projected to open the year at $253.64. The stock may dip to $168.42 during mid-year and finish the year at $186.19. Compared to the stock's current price, this translates to an overall gain of 1782.56% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
MNMD Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | - | $5.52 | 73.58% ▲ | $179.37 ▲ |
| ADTX | Aditxt, Inc. | - | $0.07 | -34.58% ▼ | $1328.57 ▲ |
| CRSP | CRISPR Therapeutics AG | - | $49.72 | 19.55% ▲ | $90.65 ▲ |
| GALT | Galectin Therapeutics Inc. | - | $1.41 | 12.80% ▲ | $268.23 ▲ |
| MBRX | Moleculin Biotech, Inc. | - | $2.18 | 44.37% ▲ | $336.52 ▲ |
Last updated Feb 18 at 3:12 AM
MNMD : Buy, Sell Or Hold?
Analyst Ratings
Based on 10 analysts, 3 rated as a strong buy, 7 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 9 analysts, 4 analysts gave a strong buy rating, 5 a buy rating, 0 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for MNMD stock is Buy.
Expert Analysis
According to MNMD short-term and long-term forecast, Mind Medicine (MindMed) Inc. shares are projected to go up by 1782.61%, and reach a value of $186.19 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 71.42857142857143, which signals Greed. Also, MNMD has recorded 11/30 green days, which reflects a 50.0% positivity rate with a price volatility of 0.07%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that MNMD stock is undervalued. So, Based on MNMD prediction and analysis, it may be the best time to hold MNMD stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "MNMD” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.